We refer to the previous announcements and the abridged prospectus dated 3 October 2022 in relation to the Rights Issue with Warrants (“Abridged Prospectus”). Unless otherwise stated, the terms used herein shall have the same meaning as those defined in the Abridged Prospectus.

On behalf of the Board, UOBKH wishes to announce that as at the close of acceptance, excess application and payment for the Rights Issue with Warrants at 5.00 p.m. on Wednesday, 19 October 2022, the total acceptances and excess applications for the Rights Issue with Warrants were 119,102,032 Rights Shares, which represents an over-subscription of 35.34% over the total number of Rights Shares available for subscription under the Rights Issue with Warrants.

The details of the subscription are set out below:-

The Excess Rights Shares with Warrants will be allotted on a fair and equitable manner and in the following priority:-

1. firstly, to minimise the incidence of odd lots;
2. secondly, for allocation to Entitled Shareholders who have applied for the Excess Rights Shares with Warrants, on a pro-rata basis and in board lot, calculated based on their respective shareholdings in HYB as at the Entitlement Date;
3. thirdly, for allocation to Entitled Shareholders who have applied for the Excess Rights Shares with Warrants, on a pro-rata basis and in board lot, calculated based on the quantum of their respective Excess Rights Shares with Warrants applied for; and
4. finally, for allocation to renouncee(s)/transferee(s) (if applicable) who have applied for the Excess Rights Shares with Warrants, on a pro-rata basis and in board lot, calculated based on the quantum of their respective Excess Rights Shares with Warrants applied for.

In the event there is any remaining balance of the Excess Rights Shares with Warrants applied for by the Entitled Shareholders and/or their renouncee(s)/transferee(s) (if applicable) who have applied for the Excess Rights Shares with Warrants after carrying out steps (1) to (4) as set out above, steps (2) to (4) will be repeated in the same sequence to allocate the remaining balance of the Excess Rights Shares with Warrants to the Entitled Shareholders and/or their renouncee(s)/transferee(s) (if applicable) who have applied for the Excess Rights Shares with Warrants until such balance is fully allocated.

Any remaining Excess Rights Shares with Warrants thereafter which HYB is unable to allocate to the Entitled Shareholders and/or their renouncee(s)/transferee(s) (if applicable) will then be allocated to the major shareholders at the discretion of the Board.

Nevertheless, the Board reserves the right to allot any Excess Rights Shares with Warrants   applied for in such manner as the Board deems fit and expedient in the best interest of HYB, subject always to such allocation being made on a fair and equitable basis, and that the intention of the Board as set out in steps (1) to (4) above are achieved.

This announcement is dated 25 October 2022